EP0197985A1 - Kosmetische zusammensetzungen - Google Patents

Kosmetische zusammensetzungen

Info

Publication number
EP0197985A1
EP0197985A1 EP85904943A EP85904943A EP0197985A1 EP 0197985 A1 EP0197985 A1 EP 0197985A1 EP 85904943 A EP85904943 A EP 85904943A EP 85904943 A EP85904943 A EP 85904943A EP 0197985 A1 EP0197985 A1 EP 0197985A1
Authority
EP
European Patent Office
Prior art keywords
composition
biguanide
cosmetic
buffer
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP85904943A
Other languages
English (en)
French (fr)
Other versions
EP0197985A4 (de
Inventor
Lai Ogunbiyi
Francis X. Smith
Thomas M. Riedhammer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27097082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0197985(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Publication of EP0197985A1 publication Critical patent/EP0197985A1/de
Publication of EP0197985A4 publication Critical patent/EP0197985A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/37Polymers
    • C11D3/3703Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C11D3/3723Polyamines or polyalkyleneimines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A01N47/42Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
    • A01N47/44Guanidine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/141Biguanides, e.g. chlorhexidine
    • A61L12/142Polymeric biguanides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0078Compositions for cleaning contact lenses, spectacles or lenses
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives

Definitions

  • This invention relates to cosmetic compositions and, more specifically, to such compositions containing an antimicrobial preservative.
  • Preservatives are desirable additions to cosmetic products for inhibiting the growth of microorganisms. In higher concentrations, certain substances also function as antiseptic or anti-fungal agents. Nevertheless, due to the ability to irritate the skin and create other dermatologic reactions, preservatives in cosmetic products must not exceed specific authorized concentrations.
  • preservatives examples include benzoic acid, salts and esters (0.5%), propionic acid and its salts (2%-acid) and polyhexamethylene biguanide hydrochloride (0.3%).
  • Polyhexamethylene biguanide also known as PHMB
  • PHMB Polyhexamethylene biguanide
  • the present invention is based on the discovery that cosmetic formulations comprising various aqueous solutions, aqueous suspensions, powders, gels, creams, cakes, water base ointments, pastes and the like can be preserved with unexpectedly low concentrations of PHMB when a buffer is included in the formulation.
  • concentration of PHMB is reduced even more by including components which are surprisingly synergistic with PHMB.
  • the preserved cosmetic compositions of the present invention are especially suitable for use near the eyes.
  • compositions of the invention have a wide spectrum of bactericidal and fungicidal or bacteriostatic and fungistatic activity, because of the low concentration of PHMB which the invention makes possible, the novel compositions also are non-toxic and non-irritating to the skin.
  • This invention provides a non-toxic, non-irritating cosmetic composition which is preserved against microbial or fungal growth, the composition comprising an oil-in-water or water-in-oil emulsion, a microbicidally effective amount of a biguanide or water-soluble salt thereof, in combination with a buffer system, said biguanide having the formula:
  • n is from 1 to 500.
  • the biguanides for use in the present invention include hexamethylene biguanides, their polymers and water-soluble salts of such base compounds and polymers.
  • the polymers have molecular weights of up to about 100,000 and are present in amounts from about 0.5 to about 100 parts by weight per hundred parts of the cosmetic composition.
  • the antibacterial action of the biguanide-containing compositions described herein may also be supplemented by the addition of other germicidal agents. Because the overall germicidal activity of such combinations will in some instances be greater than when each is used separately, the concentration of total disinfectant in solution can be lowered, further reducing the potential adverse toxic reactions..
  • compositions of the present invention are effective at low concentrations against a wide spectrum of microorganisms, including but not limited to S. epidermidis, C. albicans, A. fumigatus, etc.
  • the compositions contain as their principal microbicide a biguanide of formula I, including low molecular weight oligomers where n averages from 4 to 7, high molecular weight long chain polymers up to approximately 100,000 M.W., as well as individual monomers of such polymers where n is 1.
  • the biguanides can be in the form of water-soluble salts of the free bases, such as hydrochloride and borate salts, acetate, gluconate, sulfonate, tartrate and citrate salts.
  • water-soluble salts e.g. , hydrochloride
  • the value for n generally averages between 2 and 12, and more specifically from 3 to 8.
  • one preferred group of water-soluble biguanides described herein will have average molecular weights of at least 1,000 and more particularly from 1,000 to 50,000 M. .
  • polymeric and monomeric biguanides within the foregoing broad definition for use in the solutions of the present invention is surprising and unexpected, since polymers in the higher molecular weight ranges usually demonstrate lower toxicity levels than corresponding lower molecular weight materials.
  • the monomer e.g. , hexa ethylene biguanide hydrochloride, provides good bactericidal activity at low concentrations as does polyhexamethylene biguanide hydrochloride wherein n averages 4 to 7.
  • the cosmetic compositions of this invention contain a buffer, preferably a borate buffer, e.g., boric acid, sodium borate, potassium tetraborate, potassium metaborate or mixtures of the same.
  • a borate buffer is exceptionally effective in permitting the use of concentrations of PHMB in cosmetic compositions which are lower than would be microbicidally effective without a buffer or with other buffers.
  • buffers in this category are sodium or potassium citrate, citric acid, sodium bicarbonate and various mixed phosphate buffers, including combinations of Na-HPO, NaH-PO. and KH-PO..
  • buffers may be used in amounts ranging from about 0.05 to about 2.5 percent, and more preferably, from about 0.1 to about 1.5 percent (w/w) .
  • PHMB Borate buffers yield best results with PHMB at concentrations from about 0.1 to about 2.5 weight percent for boric acid and about 0.10 to about 1.5 weight percent for sodium borate.
  • Suitable sequestering agents include ethylene diaminetetraacetic acid (EDTA), gluconic acid, citric acid, tartaric acid and their salts, e.g. , sodium.
  • EDTA ethylene diaminetetraacetic acid
  • gluconic acid gluconic acid
  • citric acid citric acid
  • tartaric acid tartaric acid
  • salts e.g. , sodium.
  • the foregoing surfactants, when employed as a buffer enhancer will be present in an amount from 0.0001 percent to 5.0 percent (w/w) percent to 5.0 percent (w/w).
  • the amphoteric charged surfactant molecule consists of a relatively complex organic portion with a net positive or negative charge.
  • the latter charge is balanced by a positive or negative counterion; (e.g. , Na + , C1-) which is not connected to the molecule by a between the oppositely charged moieties.
  • the complex organic portion referred to above contains both positive and negative charges (at least one of each).
  • electrical neutrality is provided by counterions, both negative and positive counterions being required for the same molecule.
  • the uncharged portion of the amphoteric molecule contains hydrophobic groups (the charged portions usually function as a part of the hydrophilic groups) and may contain non-charged (i.e. non-ionic) hydrophilic groups.
  • a preferred amphoteric surfactant molecule of this invention is illustrated by the following chemical structures:
  • R represents a fatty acid radical of C -C , e.g., coconut oil which is a mixture of lauric, myristic, oleic, stearic, palmitic and other similar acids; lauric acid; capric acid; caprylic and ethylhexoic acid; oleic acid; linoleic acid and stearic acid; R 2 is -7-
  • M and M. are cation salt forming groups, such as hydrogen or alkali metals
  • X is OH
  • the acid group of an anionic surface active agent e.g. , sodium lauryl sulfate or sodium lauryl sulfonate
  • R.. is H or
  • n is an integer from 1 to 40.
  • Materials of this type are offered commercially from the Miranol Chemical Co., Doyton, NJ 08810 under the trade name "Miranol.”
  • Typical examples of ionized amphoteric salts are shown below:
  • these compounds can be monocarboxylate, dicarboxylates or sulfonates.
  • the counterions in the first example are Na and CH _H» ⁇ 0S0_ - and in the second example Na and OH .
  • amphoteric surfactants is given by the following chemical structure in the ionized form:
  • R is a hydrophobe radical such as methyl octadecyl, methyldodecyl, methyloctadecenyl, etc.
  • M is an alkali metal, such as Na, K, etc.
  • X is the negative part of an agent, such as CH_0S0 3 , C 2 H-OS0 3 , Cl, Br, etc.
  • n is an integer from 1 to 40. Materials of this type are available commercially from Armstrong Chemical Co., Inc., Janesville, WI 53545 under the trade name Sanac. This molecule has a nonionic functionality ⁇ *, (C2 threadH4.O)nH.
  • amphoteric surfactants may be exemplified by the following chemical structure, in the ionized form:
  • R is a fatty acid radical or other hydrophobe radical
  • R 2 is an alkyl or substituted alkyl radical
  • Z is a sulfate or sulfonic group, e.g. , -SO., -CH 2 CH 2 S0 3
  • M is an alkali metal such as Na or R
  • x is the negative radical from a quaternizing reagent such as CH-OS0 3 , C 2 H_OS0 3 , Cl, Br. etc.
  • amphoteric surfactants may be exemplified by the following chemical structure in the ionized form: -10-
  • R is alkylene having 12 to 13 atoms and R-C0- taken together as the acid radical such as coconut acid.
  • Materials of this type are exemplified by cocoamidopropyl betaine commercially available from Stephen Chemical Co., Northfield, IL 60093 under the trade name Amphosol CA.
  • dual quaternary ammonium compositions are described in U.S. patent 3,525,793 and 3,472,939 and are commercially available from Onyx Chemical Company, Jersey City, NJ under the trademark BTS 2125M.
  • neutral or non-ionic surfactants When used, neutral or non-ionic surfactants impart cleaning and conditioning properties and are usually present in amounts up to 15 weight percent.
  • the surfactant should be soluble in the cosmetic composition, non-irritating to eye and other tissues and still usually have a hydrophilic-lipophile balance (HLB) of 12.4 to 18.8.
  • Satisfactory non-ionic surfactants include polyethylene glycol esters of fatty acids, e.g. , coconut, polysorbate, polyoxyethylene or polyoxypropylene ethers of higher alkanes (C 12 -C. fi ).
  • Examples of the preferred class include polysorbate 20 (available from ICI Americas Inc., Wilmington, DE 19897 under the trademark Tween 20), polyoxyethylene (23) lauryl ether (Brig® 35), polyoxyethylene (40) stearate (Myrj® 52), polyoxyethylene (25) propylene glycol stearate (Atlas ® G 2612).
  • Brij® 35, Myrj ® 52 and Atlas ® G 2612 are trademarks of, and are commercially available from ICI Americas Inc., Wilmington, DE 19897.
  • Non-ionic surfactant in particular, consisting of a poly (oxypropylene) -poly (oxyethylene) adduct of ethylene diamine having a molecular weight from about 7,50 to about 27,000 wherein at least 40 weight percent of said adduct is poly (oxyethylene), has been found to be particularly advantageous when used in amounts from about 0.01 to about 15 weight percent.
  • CTFA Cosmetic Ingredient Dictionary's adopted name for this group of surfactants is poloxamine.
  • Such surfactants are available from BASF Wyandotte Corp., Wyandotte, Michigan, under the registered trademark "Tetronic”.
  • An analogous series of surfactants is the poloxamine series which is a polyoxyethylene, polyoxypropylene block polymers available from BASF Wyandotte Corp., Parsippany, NJ 07054 under the trademark "Pluronic".
  • amphoteric, cationic and non-ionic surfactants suitable for use in the invention can be readily ascertained, in view of the foregoing description, from McCutcheon's Detergents and Emulsifiers, North American Edition, McCutcheon Division, MC Publishing Co., Glen Rock, NJ 07452.
  • a second disinfectant/germicide can be employed as a solution preservative, but it may also function to potentiate, complement or broaden the spectrum of microbicidal activity of PHMB.
  • Suitable complementary germicidal agents include, but are not limited to thimerosal, sorbic acid, 1,5-pentanediol, alkyl triethanolamines, phenylmercuric salts, e.g.
  • Suitable salts are soluble in water at ambient temperature to the extent of at east 0.5 weight percent. These salts include the gluconate, isothionate (2-hydroxyethanesulfonate), formate, acetate, glutamate, succinanate, monodiglycollate, dimethanesulfonate, lactate, diisobutyrate and glucoheptonate.
  • potentiating or complementary disinfecting agents for use with PHMB also include certain quaternary ammonium compounds which possess a generally wide spectrum of bactericidal activity and wetting properties.
  • Representative examples of the quaternary ammonium compounds are compositions comprised of balanced mixtures of n-alkyl dimethyl benzyl ammonium chlorides.
  • the PHMD buffer preservative systems are adequate at the level of from about 0.5 ppm to about 100 ppm to preserve the products by inhibiting microbial and fungal growth.
  • Cosmetic products of particular interest within the scope of the instant invention include but are not limited to eye makeup remover, mascara and eye shadow.
  • the PHMD buffer/preserva ⁇ tive system works in aqueous solution, aqueous suspension, powders, gels, creams, cakes, water base ointments, pastes and the like.
  • the buffer is preferably a borate, e.g. , boric acid, sodium borate, potassium tetraborate, potassium metaborate or mixtures of the same.
  • the concentration of PHMB in the compositions of the invention can range from about 0.5 ppm to about 100 ppm, which is lower than the prior art suggests for cosmetic compositions containing PHMB, the concentration in cosmetic compositions having high solids content should be substantially above the lower end of the range.
  • cosmetic creams, pastes, cakes, powders and the like have a substantially higher solids content than aqueous solutions and gels such as the aqueous eye makeup remover and the gel eye makeup remover described in examples hereinafter.
  • the concentration of PHMB should be in the range from about 10 to about 100 ppm and preferably is in the range from about 40 to about 60 ppm. At these concentrations PHMB when used with a buffer such as borate is effective for preserving the compositions and the compositions are essentially nonirritating to the skin.
  • the PHMD preservative can be incorporated into the cosmetic formulations according to conventional procedures well known in the art. Typically, the formulation process depends upon the aqueous nature of the preservative system. For example, if the product has an oil phase, it may be desirable to create an oil-in-water emulsion. Nevertheless, the exact method of preparation is not critical to this invention.
  • An aqueous eye makeup remover is prepared with the following formulation:
  • Poloxamine 407 Surfactant 1. , 00
  • Poloxamine 407 Surfactant 22. .00
  • a crea ⁇ eye makeup remover is prepared with the following formulation:
  • Purified water q.s. to 100.0 1.
  • the product of Example III may be prepared by mixing the ingredients of Parts A, B and C separately. The mixtures of Parts A and B are then emulsified together. Part C is added to the emulsified material to produce the final product.
  • a cake mascara is prepared with the following formulation:
  • a liquid eye shadow is prepared with the following formulation:
  • a cationic cellulosic resin available from Union Carbide Co.. Danbury, CT.
  • a mixture of certain ingredients enhances the capacity of the PHMB preservative to withstand microbial insult and also widens the range of microorganisms against which the cosmetic composition is protected.
  • Such a preferred composition contains, in addition to PHMB and the selected cosmetic ingredients, a second antimicrobial preservative such as diazolidinyl urea, the borate buffer system (sodium borate and boric acid) and an amphoteric or non-ionic surfactant.
  • a preferred amphoteric surfactant is cocamidopropyl betaine and a preferred non-ionic surfactant is the poloxamine known as "Tetronic 1107" surfactant.
  • Preferred concentration ranges for the components of this kind of synergistic composition are:
EP19850904943 1984-09-28 1985-09-26 Kosmetische zusammensetzungen. Withdrawn EP0197985A4 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65596584A 1984-09-28 1984-09-28
US655965 1984-09-28
US68045084A 1984-12-11 1984-12-11
US680450 1984-12-11

Publications (2)

Publication Number Publication Date
EP0197985A1 true EP0197985A1 (de) 1986-10-22
EP0197985A4 EP0197985A4 (de) 1987-02-19

Family

ID=27097082

Family Applications (2)

Application Number Title Priority Date Filing Date
EP19850306391 Expired - Lifetime EP0180309B2 (de) 1984-09-28 1985-09-09 Desinfektions- und Aufbewahrungslösungen für Kontaktlinsen und Verfahren zur Verwendung
EP19850904943 Withdrawn EP0197985A4 (de) 1984-09-28 1985-09-26 Kosmetische zusammensetzungen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP19850306391 Expired - Lifetime EP0180309B2 (de) 1984-09-28 1985-09-09 Desinfektions- und Aufbewahrungslösungen für Kontaktlinsen und Verfahren zur Verwendung

Country Status (8)

Country Link
EP (2) EP0180309B2 (de)
JP (2) JPH0649642B2 (de)
CA (1) CA1259542A (de)
DE (1) DE3585400D1 (de)
ES (1) ES8802091A1 (de)
HK (1) HK39292A (de)
SG (1) SG38292G (de)
WO (1) WO1986002001A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1259542A (en) * 1984-09-28 1989-09-19 Francis X. Smith Disinfecting and preserving solutions for contact lenses and methods of use
GB2188744B (en) * 1986-04-01 1989-11-15 Donald James Highgate Contact lens cleaners
EP0324211A1 (de) * 1988-01-12 1989-07-19 Bosshardt-Chemie AG Verwendung von Mischungen zur Geruchsentfernung
US4837079A (en) * 1988-09-09 1989-06-06 James River Corporation Antimicrobially active, non-woven web used in a wet wiper
US5037647A (en) * 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
CA2009118C (en) * 1989-02-21 1996-02-27 Mary F. Mowrey-Mckee Method and composition for cleaning and disinfecting contact lenses
GB9024133D0 (en) 1990-11-06 1990-12-19 Ici Plc Aqueous composition
US5356555A (en) * 1992-09-14 1994-10-18 Allergan, Inc. Non-oxidative method and composition for simultaneously cleaning and disinfecting contact lenses using a protease with a disinfectant
US5300287A (en) * 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
ES2122288T3 (es) * 1993-05-26 1998-12-16 Fresenius Ag Antiinfeccioso.
JPH0892017A (ja) 1994-09-19 1996-04-09 Tomey Technol Corp コンタクトレンズ用液剤
US6126936A (en) * 1995-03-10 2000-10-03 Biohybrid Technologies Llc Microcapsules and composite microreactors for immunoisolation of cells
GB9506841D0 (en) * 1995-04-03 1995-05-24 Unilever Plc Deodorant compositions
US5747017A (en) * 1995-05-15 1998-05-05 Lip-Ink International Lip cosmetic
WO1997028827A1 (fr) * 1996-02-07 1997-08-14 Rohto Pharmaceutical Co., Ltd. Composition ophtalmique possedant une viscosite adaptee
DE19604475A1 (de) * 1996-02-08 1997-08-14 Fresenius Ag Verwendung von PHMB zur Behandlung von durch sich intrazellulär vermehrende Erreger verursachten Infektionen
JP3698832B2 (ja) * 1996-10-08 2005-09-21 株式会社メニコン コンタクトレンズ用液剤
JP4064625B2 (ja) 1997-11-26 2008-03-19 アドバンスト メディカル オプティクス, インコーポレーテッド コンタクトレンズ洗浄組成物
US6190681B1 (en) 1998-04-15 2001-02-20 Yoram Fishman Long lasting liquid color compositions
US6261576B1 (en) * 1998-04-15 2001-07-17 Yoram Fishman Long-lasting liquid color formulations
FR2780641B1 (fr) * 1998-07-01 2000-08-11 Oreal Composition cosmetique et/ou dermatologique biphasee, utile notamment pour le demaquillage des yeux
JP4536175B2 (ja) * 1998-09-18 2010-09-01 日油株式会社 防腐剤組成物
EP1050304A1 (de) 1998-11-16 2000-11-08 Rohto Pharmaceutical Co., Ltd. Flüssige augenarznei-zusammensetzungen
US6309596B1 (en) * 1998-12-15 2001-10-30 Bausch & Lomb Incorporated Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by a poloxamine
US6369112B1 (en) * 1998-12-15 2002-04-09 Bausch & Lomb Incorporated Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by tyloxapol
EP1204324B1 (de) * 1999-08-02 2010-10-06 Gordon L. Dorn System zur stabilisierung von proben
US6716632B1 (en) 1999-08-02 2004-04-06 Gordon L. Dorn System for stabilizing samples
US7122505B1 (en) * 1999-10-21 2006-10-17 Arch Chemicals Inc. Composition for controlling the growth of algae, fungi and pathogenic organisms in water
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
JP4902064B2 (ja) * 2000-08-16 2012-03-21 株式会社クラレ コンタクトレンズ用液剤
US20020115578A1 (en) * 2000-12-14 2002-08-22 Groemminger Suzanne F. Composition for cleaning and wetting contact lenses
MY128762A (en) 2001-01-12 2007-02-28 Novartis Ag Lens care product containing dexpanthenol
CA2443472A1 (en) * 2002-02-07 2003-08-14 Ophtecs Corporation Liquid formulation for contact lenses
JP2005008596A (ja) * 2003-06-20 2005-01-13 Kobayashi Pharmaceut Co Ltd 眼科用組成物
US20050119141A1 (en) * 2003-12-01 2005-06-02 Irene Quenville Stability enhancement of solutions containing antimicrobial agents
SI1755576T1 (sl) 2004-04-08 2011-12-30 Dermcare Vet Pty Ltd Antimikrobni sestavki in postopki za njihovo uporabo
US20060067964A1 (en) * 2004-09-30 2006-03-30 Kimberly-Clark Worldwide, Inc. Decal that includes synergistic antimicrobials for treating surfaces
JP4781663B2 (ja) * 2004-11-17 2011-09-28 花王株式会社 抗菌剤
JP5135526B2 (ja) * 2005-06-27 2013-02-06 株式会社メニコンネクト コンタクトレンズ用液剤
EP2503883B1 (de) 2009-11-24 2016-03-02 Fresenius Medical Care Deutschland GmbH Desinfizierende zusammensetzung
TW201138843A (en) 2009-12-18 2011-11-16 Colgate Palmolive Co Biguanide preservation of precipitated calcium carbonate
CN102119932A (zh) * 2009-12-25 2011-07-13 日本乐敦制药株式会社 硅酮水凝胶隐形眼镜用眼科组合物
JP5627235B2 (ja) * 2009-12-28 2014-11-19 小林製薬株式会社 眼科用組成物
KR20130041803A (ko) * 2010-04-07 2013-04-25 알러간, 인코포레이티드 안과 조성물을 위한 보존제의 조합

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2182962A1 (de) * 1972-04-13 1973-12-14 Smtih Nephew Research Ltd

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US388782A (en) * 1888-08-28 William a
GB1407258A (en) * 1972-12-18 1975-09-24 Ici Ltd Water treatment
US3860729A (en) * 1973-10-05 1975-01-14 Schaefer Brewing Co Preservation of beverages with poly(hexamethylenebiguanide hydrochloride)
US4013576A (en) * 1973-11-21 1977-03-22 Wesley-Jessen Inc. Contact lens treating composition
GB1464005A (en) * 1974-04-22 1977-02-09 Ici Ltd Method for the destruction of aquatic molluscs
DE3012767A1 (de) * 1980-04-02 1981-10-08 Wella Ag Kosmetische mittel
FR2483177A1 (fr) * 1980-05-29 1981-12-04 Salkin Nicolas Nouvelle composition desinfectante comprenant un ammonium quaternaire et un oligomere de chlorhydrate d'hexamethylene biguanide
US4361548A (en) * 1980-11-28 1982-11-30 Bausch & Lomb Incorporated Contact lens disinfecting and preserving solution (polymeric)
US4354952A (en) * 1981-03-12 1982-10-19 Bausch & Lomb Incorporated Contact lens disinfecting and preserving solution comprising chlorhexidine and salts thereof
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
FR2517208A1 (fr) * 1981-12-02 1983-06-03 Pos Lab Composition pour le nettoyage et la sterilisation de protheses oculaires et auriculaires
US4478821A (en) * 1982-01-26 1984-10-23 The Gillette Company Inhibition of body odor
CA1226213A (en) * 1982-09-24 1987-09-01 Johnson & Johnson Baby Products Company Antimicrobial compositions
CA1259542A (en) * 1984-09-28 1989-09-19 Francis X. Smith Disinfecting and preserving solutions for contact lenses and methods of use
TW203128B (en) * 1992-06-17 1993-04-01 Ciba Geigy Ag The protection method for hard and soft contact lens
JP3337497B2 (ja) * 1992-07-28 2002-10-21 株式会社クラレ 連続式成膜装置

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2182962A1 (de) * 1972-04-13 1973-12-14 Smtih Nephew Research Ltd

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8602001A1 *

Also Published As

Publication number Publication date
EP0180309B2 (de) 1997-12-17
WO1986002001A1 (en) 1986-04-10
ES8802091A1 (es) 1988-03-16
SG38292G (en) 1992-05-22
JPS6185301A (ja) 1986-04-30
JPH0649642B2 (ja) 1994-06-29
EP0180309A1 (de) 1986-05-07
ES547368A0 (es) 1988-03-16
JPH06321715A (ja) 1994-11-22
EP0197985A4 (de) 1987-02-19
EP0180309B1 (de) 1992-02-19
CA1259542A (en) 1989-09-19
DE3585400D1 (de) 1992-03-26
HK39292A (en) 1992-06-04
JP2554237B2 (ja) 1996-11-13

Similar Documents

Publication Publication Date Title
EP0197985A1 (de) Kosmetische zusammensetzungen
EP2618806B1 (de) Antimikrobielle zusammensetzungen mit kationischen wirkstoffen und aus quaternären zuckern gewonnenen tensiden
US4836986A (en) Disinfecting and preserving systems and methods of use
US4758595A (en) Disinfecting and preserving systems and methods of use
EP0987321B1 (de) Ultramilde antibakterielle Reinigungsmittel für den häufigen Gebrauch
EP0983335B1 (de) Alkylpolyglycosidhaltige, gegen pseudonomas mikroorganismen wirksame desinfektionsmittel
DE60224841T2 (de) Kombinierte stabile kationische und anionische tensidzusammensetzungen
EP0197968B1 (de) Antiseptische waschmittelzusammensetzungen
US4354952A (en) Contact lens disinfecting and preserving solution comprising chlorhexidine and salts thereof
EP0911022B1 (de) Ultramilde antibakterielle Reinigungszusammensetzungen zum häufigen Gebrauch
CA2187034C (en) Use of amidoamines in ophthalmic compositions
WO1995031958A1 (en) Disinfectants and sanitizers with reduced eye irritation potential
WO1995031962A1 (en) Antimicrobial cleaning composition containing chlorhexidine, anamphoteric and an alkylpolyglucoside
WO1997048377A1 (en) Skin wash compositions comprising triclocarban and surfactants
EP0231080A1 (de) Antiseptische Zusammensetzungen
US4252826A (en) Cosmetic composition for removing makeup from the eyes
EP0339121A1 (de) Flüssige Zusammensetzung zum Waschen und Entkeimen
US20100111877A1 (en) Foam disinfectant
EP2276453B1 (de) Solubilisierendes Mittel für essentielle Öle und sie enthaltende kosmetische Zubereitungen
EP0232250B1 (de) Verfahren und loesung zur desinfektion und konservierung von kontaktlinsen
JPS62500661A (ja) 化粧料組成物
AU729662C (en) Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism
HU209860B (en) Composition for simultaneous cleaning, exemptioning from blood and disinfecting of dental prints, forms and protetic work-pieces

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19860702

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19870219

17Q First examination report despatched

Effective date: 19881020

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19890301

RIN1 Information on inventor provided before grant (corrected)

Inventor name: OGUNBIYI, LAI

Inventor name: RIEDHAMMER, THOMAS, M.

Inventor name: SMITH, FRANCIS, X.